Research Paper Volume 13, Issue 17 pp 21671—21699
Integrated analysis identifies TfR1 as a prognostic biomarker which correlates with immune infiltration in breast cancer
Figure 12. KM survival curves based on different expression levels of TfR1 in various subgroups of BC patients. (A–J) The relationship between TfR1 expression and the OS rate in diverse immune cell subgroups of BC patients was explored.